Genital wart coding – E/M code likely best bet

Why This Topic Matters

Genital wart treatment can involve several different therapeutic approaches, and the coding implications vary depending on the method used. Understanding the related CPT guidance helps avoid misclassification of services and supports more accurate reporting.

Article Sections

1. Topical chemotherapy and lesion destruction guidance

   Discusses CPT guidance related to topical chemotherapy and lesion destruction concepts in the integumentary and female genitourinary sections. The section focuses on how the article frames the relationship between office visits, chemical treatment, and lesion destruction terminology.

2. Chemical treatment options and coding considerations

   Covers common chemical and drug-based approaches used for genital wart treatment and the coding issues raised by those approaches. The discussion remains centered on broad billing categories and guideline conflicts.

3. Conflicting advice in CPT

   Addresses the article’s discussion of inconsistent CPT references involving chemical treatment terminology. It explains why the guidance is presented as conflicting without detailing code-selection logic.

4. Injections

   Summarizes the use of intralesional injections as an alternative treatment approach and notes the CPT injection services discussed in the article. The section stays at a high level and does not provide procedural detail.

5. What are genital warts?

   Provides general clinical background on genital warts, including their cause and epidemiology. This section is informational context for the coding discussion.